imatinib has been researched along with pha 680626 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SP; Cui, J; Fu, R; Li, GW; Liu, S; Qian, SX; Zhou, LH | 1 |
1 other study(ies) available for imatinib and pha 680626
| Article | Year |
|---|---|
BCR-ABL tyrosine kinase inhibitor pharmacophore model derived from a series of phenylaminopyrimidine-based (PAP) derivatives.
Topics: Drug Design; Fusion Proteins, bcr-abl; Models, Molecular; Protein Kinase Inhibitors; Pyrimidines; Quantitative Structure-Activity Relationship | 2013 |